Eos Energy Enterprises Inc vs Medpace Holdings Inc — how do they compare? Eos Energy Enterprises Inc trades at $4.18 (market cap $1.54B), while Medpace Holdings Inc trades at $599.07 (market cap $16.90B). The key difference: Medpace Holdings Inc is far larger — about 11× Eos Energy Enterprises Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Eos Energy Enterprises Inc nearer its low. Which is the better fit depends on your goals.
| EOSE | MEDP | |
|---|---|---|
Market Cap | $1.54B | $16.90B |
Sector | Energy | Technology |
52-Week High | $19.19 | $620.59 |
52-Week Low | $3.14 | $393.42 |
Enterprise Value | $1.88B | $16.52B |
Signals from Pluang's Aura AI — not financial advice
Eos Energy Enterprises (EOSE) trades at $4.38, up 8.15% on the day, amid mixed technical signals and persistent fundamental challenges. The company reported a Q2 2026 loss of $1.20 per share, missing estimates, but revenue growth is accelerating, with 2026 revenue projected at $214 million. Negative profit margins and cash burn remain significant concerns, though analyst sentiment shows a mixed but cautious outlook with a consensus price target of $7.75.
The stock presents a high-risk opportunity driven by revenue growth potential in energy storage, but investors face substantial risks from continued losses, dilution, and competitive pressures. Upside depends on execution improving margins and achieving profitability, while downside risks include further earnings misses and liquidity challenges.
MEDP trades at $600.32, down 0.35% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with Q2 2026 earnings beating estimates at $4.25 per share versus $3.98 expected, and revenue growth projected from $2.53B in 2025 to $2.8B in 2026. Recent news highlights record bookings and raised guidance, though valuation ratios remain elevated with a P/E of 35.58 and P/B of 38.95.
Outlook remains positive driven by earnings momentum and strong backlog visibility, but risks include premium valuation compression and ongoing legal scrutiny. Analyst consensus is cautious with 73.7% hold ratings, though institutional interest persists with California State Teachers Retirement System increasing its position by 22.1% in Q1 2026.
Trailing returns across standard periods
Latest headlines on both assets
Eos Energy Enterprises provides long-duration energy storage solutions. Its signature zinc-based batteries are designed for utility-scale applications, helping to stabilize power grids and integrate renewable energy.
Read more on EOSE →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →